Advertisement

Supply Chain



KemPharm announced Monday that the Food and Drug Administration did not approve the drug maker's abuse-deterrent version of a painkiller.

A safety warning issued in 2011 by the Food and Drug Administration over the dosage of an antibiotic backfired, leading to intensified depressive symptoms and more hospitalizations among patients whose conditions were previously stabilized on higher doses of the drugs,…

In 2012, the Food and Drug Administration Safety and Innovation Act gave the FDA expanded powers to monitor and resolve drug shortages. A recent paper in Health Affairs evaluated trends in drug shortages before and after the passage of act…

Advertisement

Most Read

Advertisement
Advertisement